Cullen Michael T. 13D and 13G filings for Panbela Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 2:45 pm Purchase | 2022-12-31 | 13G | Panbela Therapeutics, Inc. PBLA | Cullen Michael T. | 58 3.300% | 22 (+60.55%) | Filing |
| 2022-02-14 5:20 pm Purchase | 2021-12-31 | 13G | Panbela Therapeutics, Inc. PBLA | Cullen Michael T. | 36 6.300% | 2 (+5.57%) | Filing |
| 2021-02-16 4:06 pm Purchase | 2020-12-31 | 13G | Panbela Therapeutics, Inc. PBLA | Cullen Michael T. | 34 8.200% | 34 (New Position) | Filing |